Today's Brokerage Rating: Gilead Sciences, Inc. (GILD), Denbury Resources Inc. (DNR)

Adjust Comment Print

Artal Group Sa sold 1.00M shares as Gilead Sciences Inc (Call) (GILD)'s stock declined 8.05%. The institutional investor held 7,550 shares of the health care company at the end of 2017Q3, valued at $612,000, down from 11,450 at the end of the previous reported quarter. The stock decreased 0.24% or $0.2 during the last trading session, reaching $81.62. The stock ended last trade at 80.79 a share and the price is up more than 12.77% so far this year.

Gilead Sciences (NASDAQ:GILD) last announced its quarterly earnings results on Tuesday, February 6th.

Zevenbergen Capital Investments Llc decreased its stake in Facebook Inc.

Paradice Investment Management Llc increased its stake in Orthofix Intl N V (OFIX) by 10.01% based on its latest 2017Q3 regulatory filing with the SEC. Ruffer Llp bought 1.55M shares as the company's stock declined 6.89% while stock markets rallied. The institutional investor held 49,445 shares of the containers and packaging company at the end of 2017Q3, valued at $5.82M, down from 54,413 at the end of the previous reported quarter. Advisors Asset Management Inc who had been investing in Whitehorse Fin Inc for a number of months, seems to be less bullish one the $245.36M market cap company. The stock decreased 0.37% or $0.55 during the last trading session, reaching $148.31. About 195,668 shares traded. Alibaba Group Holding Limited (NYSE:BABA) has risen 57.33% since February 14, 2017 and is uptrending.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.22, from 1.26 in 2017Q2. Illinois-based Cibc Savings Bank Usa has invested 0.03% in NIKE, Inc. Wealthtrust reported 3,033 shares stake. Homrich And Berg holds 0.03% or 11,475 shares in its portfolio. Heartland Advisors Inc, a Wisconsin-based fund reported 350,720 shares. 250 were reported by Barnett & Inc. (NASDAQ:FB) on Monday, August 21. Aureus Asset Mgmt Limited Company accumulated 4,832 shares. Halsey Assocs Ct has 3.25% invested in Facebook, Inc. Rock Springs Cap Management Ltd Partnership holds 313,400 shares or 1.17% of its portfolio. Employees Retirement Sys Of Texas invested in 0.04% or 29,000 shares. Commonwealth Equity Services invested in 0.15% or 317,465 shares. Skandinaviska Enskilda Banken AB publ grew its position in shares of Gilead Sciences by 230.0% during the third quarter. Hillsdale Inv Management holds 0.08% or 5,510 shares. Oakwood Cap Mngmt Ltd Liability Company Ca reported 50,315 shares. The Connecticut-based Thomson Horstmann & Bryant Inc has invested 1.15% in the stock. The firm has "Buy" rating given on Wednesday, August 9 by Gabelli. $21.25 million worth of stock was sold by Zuckerberg Mark on Friday, December 8. Alton Gregg H sold $2.09 million worth of Gilead Sciences, Inc. The shares were sold at an average price of $77.92, for a total transaction of $4,675,200.00. It is negative, as 67 investors sold EOG shares while 337 reduced holdings. Another trade for 2.95M shares valued at $502.59M was sold by Koum Jan. It also increased its holding in Visa Inc.

More news: Ankara, Athens discussed incident in Aegean Sea
More news: Paul Dummett: Newcastle United left-back signs new deal until 2022
More news: Analysts Estimates And Ratings The Walt Disney Company (DIS)

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 74% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. (NASDAQ:GILD) on Tuesday, October 20 with "Outperform" rating. The firm has "Equal-Weight" rating by Morgan Stanley given on Thursday, May 26. The firm has "Outperform" rating given on Wednesday, November 2 by RBC Capital Markets. The company's 3-months average volume stands at 4.84 million. As per Thursday, February 2, the company rating was maintained by FBR Capital. The firm earned "Buy" rating on Wednesday, July 29 by Needham. The rating was maintained by Stifel Nicolaus with "Buy" on Thursday, January 28. The stock of EOG Resources, Inc. (NASDAQ:GILD) earned "Buy" rating by Robert W. Baird on Friday, September 15. Canaccord Genuity maintained the stock with "Buy" rating in Tuesday, September 5 report. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.23% in Gilead Sciences, Inc. (NASDAQ:GILD). James Research Incorporated stated it has 32,880 shares. Piper Jaffray has "Overweight" rating and $155.0 target. The stock is now showing downward return of -1.14% throughout last week and witnessed increasing return of 1.96% in one month period. Its down 0.20, from 1 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 2,896,543 shares of the company traded hands, compared to its average volume of 9,695,563. Denbury Resources Inc. (NYSE:DNR), at its latest closing price of $1.99, it has a price-to-book ratio of 1.59, compared to an industry average at 0.92. (NASDAQ:GILD). Asset Mngmt Inc reported 191,770 shares. Hillsdale Invest Management accumulated 5,510 shares. One Capital Mngmt Limited Liability Corporation has invested 0.56% of its portfolio in Gilead Sciences, Inc.

TRADEMARK VIOLATION NOTICE: "Investors Sell Shares of Gilead Sciences (GILD) on Strength on Insider Selling" was first reported by registrarjournal.com and is the property of of registrarjournal.com. Signia Capital Management Llc owns 98,986 shares or 3.28% of their United States portfolio. Pitcairn Com invested 0.31% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Healthinvest Prtn Ab invested in 7.25% or 76,600 shares.

Returns and Valuations for Denbury Resources Inc. (NASDAQ:GILD) for 316,312 shares. Cue has 8,071 shares. Iberiabank invested in 25,240 shares. (NASDAQ:GILD). Washington Trust Fincl Bank holds 0.02% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, September 7. Apriem Advsrs invested in 0.09% or 4,225 shares.

Since January 1, 0001, it had 0 insider buys, and 8 sales for $6.39 million activity. (GILD). GM's ROI is -1.20% while GILD has a ROI of 31.00%. It also upped Achaogen Inc (NASDAQ:AKAO) stake by 50,000 shares and now owns 250,000 shares.

Comments